Knowing a patient’s prognosis will help their medical team select the best treatment plan to minimize risk of recurrence and detrimental side effects. This information is also very helpful to determine how closely a patient needs to be followed for recurrence. For example, for patients who have not had a cancer recurrence, the risk is far lower in the fourth year after diagnosis as compared to the first year after diagnosis. Therefore, doctor visits, scans, and blood tests can be carried out less frequently when risk is lower.
The authoritative source on Merkel cell carcinoma.
June 14, 2017